Showing results (51-60 of 63) with videos related to
Sort By:
Pageof 7
Frontiers in Medicine|February 3, 2023
Reliability assessment of ultrasound muscle echogenicity in patients with rheumatic diseases: Results of a multicenter international web-based studyAndrea Di Matteo, Erica Moscioni, Maria Giovanna Lommano, et al.Medicina (Kaunas, Lithuania)|January 8, 2025
Effectiveness and Predictors of Long-Term Treatment Response to Tofacitinib in Rheumatoid Arthritis Cohort: General Analysis and Focus on High-Cardiovascular-Risk Subgroup-A Multicenter StudyMarta Priora, Andrea Becciolini, Eleonora Celletti, et al.Journal of Clinical Medicine|July 13, 2024
Influence of Safety Warnings on the Prescribing Attitude of JAK Inhibitors for Rheumatoid Arthritis in ItalyMarino Paroli, Andrea Becciolini, Alberto Lo Gullo, et al.Rheumatology (Oxford, England)|March 16, 2022
Reliability assessment of the definition of ultrasound enthesitis in SpA: results of a large, multicentre, international, web-based studyAndrea Di Matteo, Edoardo Cipolletta, Giulia Maria Destro Castaniti, et al.Therapeutic Advances in Musculoskeletal Disease|May 11, 2026
Drug retention of TNF versus IL-23 inhibitors in psoriatic arthritis: a multicenter real-life cohort studySimone Parisi, Andrea Becciolini, Bernardo D'Onofrio, et al.Frontiers in Medicine|July 23, 2026
Comparative treatment persistence of upadacitinib vs. tofacitinib in psoriatic arthritis: a multicenter observational study from the BIRRA cohortAlessandro Conforti, Martina Gentile, Valerio Cipolloni, et al.Rheumatology and Therapy|December 4, 2025
Filgotinib Effectiveness in Rheumatoid Arthritis: Observational Analysis of a Large Multicenter CohortEleonora Celletti, Myriam Di Penta, Alarico Ariani, et al.Journal of Psoriasis and Psoriatic Arthritis|June 12, 2026
Ixekizumab Treatment Persistence in Psoriatic Arthritis: Response to Joaquin et alCamilla Mazzanti, Marino Paroli, Gianluca Santoboni, et al.Journal of Psoriasis and Psoriatic Arthritis|May 16, 2025
Ixekizumab Retention Rate and Predictors of Treatment Persistence in Psoriatic Arthritis: Results of an Italian Multicenter StudyCamilla Mazzanti, Marino Paroli, Gianluca Santoboni, et al.Mediterranean Journal of Rheumatology|June 29, 2026
Real-World Effectiveness of Baricitinib in Rheumatoid Arthritis: Significant Reduction of Disease Activity Independent of Age in a Multicentre Retrospective Cohort StudyDaniele Lini, Matteo Colina, Romina Andracco, et al.Pageof 7